APOL1 and focal segmental glomerulosclerosis: Indeed, the APOL1 p.N264K missense variant was recently reported to mitigate the increased risk of CKD and ESKD in APOL1 high-risk genotypes [61] and also protected against G2-associated FSGS [62].